LY-2405319

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameLY-2405319
Drug Alias NameLY-2405319
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionMitogen-activated protein kinase stimulantsGlucose transporter 1 stimulants
TargetsMitogen-activated protein kinaseGlucose transporter 1
Therapy Area/IndicationsDiabetes Mellitus, Type 2
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesNew ZealandMexico +[5] 
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesEli Lilly And Company
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesEli Lilly And Company
Active IndicationsN/A
Inactive IndicationsDiabetes Mellitus, Type 2

Other Information

ATC CodeN/A
Related LinksN/A